OMNIAB INC (OABI) Stock Price, Quote, News and Overview
NASDAQ:OABI - Nasdaq - US68218J1034 - Common Stock - Currency: USD
OABI Quote, Performance and Key Statistics
1.76
-0.06 (-3.3%)
The current stock price of OABI is 1.76 USD. In the past month the price decreased by -28.74%. In the past year, price decreased by -60.71%.
OABI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.37 | 160.15B | ||
| DHR | DANAHER CORP | 26.46 | 141.04B | ||
| A | AGILENT TECHNOLOGIES INC | 20.02 | 30.30B | ||
| IQV | IQVIA HOLDINGS INC | 13.49 | 26.50B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.8 | 22.13B | ||
| WAT | WATERS CORP | 28.47 | 20.10B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 32.31 | 15.51B | ||
| ILMN | ILLUMINA INC | 31.57 | 12.24B | ||
| ICLR | ICON PLC | 10.35 | 11.97B | ||
| RVTY | REVVITY INC | 19.24 | 11.33B | ||
| TEM | TEMPUS AI INC | N/A | 9.15B | ||
| QGEN | QIAGEN N.V. | 19.04 | 9.09B |
Related stock screener links
About OABI
Company Profile
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 114 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. The Company’s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach, and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic target antigens.
Company Info
OMNIAB INC
5980 Horton Street, Suite 600
Emeryville CALIFORNIA US
Employees: 106
Company Website: https://www.omniab.com/
Investor Relations: http://investors.omniab.com/investors/sec-filings/default.aspx
Phone: 15102507800
OMNIAB INC / OABI FAQ
What is the stock price of OMNIAB INC today?
The current stock price of OABI is 1.76 USD. The price decreased by -3.3% in the last trading session.
What is the ticker symbol for OMNIAB INC stock?
The exchange symbol of OMNIAB INC is OABI and it is listed on the Nasdaq exchange.
On which exchange is OABI stock listed?
OABI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OMNIAB INC stock?
14 analysts have analysed OABI and the average price target is 7.99 USD. This implies a price increase of 353.98% is expected in the next year compared to the current price of 1.76. Check the OMNIAB INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OMNIAB INC worth?
OMNIAB INC (OABI) has a market capitalization of 214.95M USD. This makes OABI a Micro Cap stock.
How many employees does OMNIAB INC have?
OMNIAB INC (OABI) currently has 106 employees.
What are the support and resistance levels for OMNIAB INC (OABI) stock?
OMNIAB INC (OABI) has a resistance level at 1.84. Check the full technical report for a detailed analysis of OABI support and resistance levels.
Is OMNIAB INC (OABI) expected to grow?
The Revenue of OMNIAB INC (OABI) is expected to decline by -11.07% in the next year. Check the estimates tab for more information on the OABI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OMNIAB INC (OABI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OABI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OABI, evaluating the profitability, health, valuation and growth aspects
- OMNIAB INC (OABI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OMNIAB INC (OABI) Sales and EPS estimates to see what analysts future expectations are.
- OMNIAB INC (OABI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OMNIAB INC (OABI) Insider and Institutional Ownership to learn about the owners and their transactions.
- OMNIAB INC (OABI) Stock Chart to make your own analysis
- OMNIAB INC (OABI) Latest news and press-releases to stay up to date.
Does OMNIAB INC (OABI) stock pay dividends?
OABI does not pay a dividend.
When does OMNIAB INC (OABI) report earnings?
OMNIAB INC (OABI) will report earnings on 2025-05-08, after the market close.
What is the Price/Earnings (PE) ratio of OMNIAB INC (OABI)?
OMNIAB INC (OABI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
What is the Short Interest ratio of OMNIAB INC (OABI) stock?
The outstanding short interest for OMNIAB INC (OABI) is 9.18% of its float. Check the ownership tab for more information on the OABI short interest.
OABI Technical Analysis
OABI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OABI. While OABI has a great health rating, there are worries on its profitability.
OABI Financial Highlights
Over the last trailing twelve months OABI reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS decreased by -13.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.05% | ||
| ROE | -21.57% | ||
| Debt/Equity | 0 |
OABI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to OABI. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -2.42% and a revenue growth -11.07% for OABI